Inflation, declining FDA drug approvals will pose challenges for pharma CMOs in 2023: GlobalData Read more
Dr Reddy’s focuses on differentiated portfolio in key therapy areas for growth in India: GlobalData Read more
SII likely front-runner to win supply of HPV vaccines for Universal Immunisation Program: GlobalData Read more
Blockbuster Enhertu may get tumor agnostic label, targeting any HER2-expressing cancer: GlobalData Read more
Long road ahead for non-statin therapies in Australia dyslipidemia treatment space: GlobalData Read more